About
12.76USD+0.00 +0.00%
Closed • Updated at 16:54 GMT+00:00Market Cap$1.11B
Volume394.7K
Beta-1.30
RSI33.92
Olema Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 26 2026
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
May 21 2026
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 12 2026
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
Apr 29 2026
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Apr 21 2026
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
Recent Videos

OLMA HQ Expansion: My Take on the 8-K Filing
May 02, 2026

Olema Pharmaceuticals: March 2026 Financial and Clinical Analysis OLMA $OLMA #OLMA #stockmarket
Mar 09, 2026

Olema Pharmaceuticals, Inc. (OLMA) #Departure_of_Chief_Operating_and_Financial_Officer
Feb 04, 2026

OLMA, Olema Pharmaceuticals, Inc., 2026-01-29, stock prices dynamics, stock of the day
Jan 30, 2026
Community Chat
Ask AI
Try asking
